## Introduction

## How to use

1. download genbank file for all sequences from a specific virus
2. search PubMed for all related literature for the virus, then fetch the PDF document for all literatures and extracted related information from PDFs
3. using the two files prepared in step 1 and step 2, with the provided [tool](https://github.com/hivdb/GenBankRefs) for generating the database.
4. You can view the database using [SQLite Viewer](https://inloop.github.io/sqlite-viewer)

## CCHFV

- [Download CCHFV Database](https://github.com/hivdb/GenBankRefs/releases/download/20250110/CCHF.db)

### Related literatures

1.  Liu, K.; Li, L.; Liu, Y.; Wang, X.; Liu, J.; Li, J.; Deng, F.; Zhang, R.; Zhou, Y.; Hu, Z.; et al. Discovery of Baloxavir Sodium as a Novel Anti-CCHFV Inhibitor: Biological Evaluation of in Vitro and in Vivo. Antiviral Research 2024, 227, 105890, doi:10.1016/j.antiviral.2024.105890.
2.  Li, L.; Chong, T.; Peng, L.; Liu, Y.; Rao, G.; Fu, Y.; Shu, Y.; Shen, J.; Xiao, Q.; Liu, J.; et al. Neutralizing Monoclonal Antibodies against the Gc Fusion Loop Region of Crimean–Congo Hemorrhagic Fever Virus. PLOS Pathogens 2024, 20, e1011948, doi:10.1371/journal.ppat.1011948.
3.  Hawman, D.W.; Feldmann, H. Crimean–Congo Haemorrhagic Fever Virus. Nat Rev Microbiol 2023, 21, 463–477, doi:10.1038/s41579-023-00871-9.
4.  Teng, A.-Y.; Che, T.-L.; Zhang, A.-R.; Zhang, Y.-Y.; Xu, Q.; Wang, T.; Sun, Y.-Q.; Jiang, B.-G.; Lv, C.-L.; Chen, J.-J.; et al. Mapping the Viruses Belonging to the Order Bunyavirales in China. Infectious Diseases of Poverty 2022, 11, 81, doi:10.1186/s40249-022-00993-x.
5.  Papa (Άννα Παπά), A.; Marklewitz, M.; Paraskevopoulou (Σοφία Παρασκευοπούλου), S.; Garrison, A.R.; Alkhovsky (Альховский Сергей Владимирович), S.V.; Avšič-Županc, T.; Bente, D.A.; Bergeron, É.; Burt, F.; Di Paola, N.; et al. History and Classification of Aigai Virus (Formerly Crimean–Congo Haemorrhagic Fever Virus Genotype VI). Journal of General Virology 2022, 103, 001734, doi:10.1099/jgv.0.001734.
6.  Gordon, C.J.; Lee, H.W.; Tchesnokov, E.P.; Perry, J.K.; Feng, J.Y.; Bilello, J.P.; Porter, D.P.; Götte, M. Efficient Incorporation and Template-Dependent Polymerase Inhibition Are Major Determinants for the Broad-Spectrum Antiviral Activity of Remdesivir. Journal of Biological Chemistry 2022, 298, 101529, doi:10.1016/j.jbc.2021.101529.
7.  Gholizadeh, O.; Jafari, M.M.; Zoobinparan, R.; Yasamineh, S.; Tabatabaie, R.; Akbarzadeh, S.; Amini, P.; Eslami, M.; Yousefi, B.; Dadashpour, M. Recent Advances in Treatment Crimean–Congo Hemorrhagic Fever Virus: A Concise Overview. Microbial Pathogenesis 2022, 169, 105657, doi:10.1016/j.micpath.2022.105657.
8.  Fabara, S.P.; Ortiz, J.F.; Smith, D.W.; Parwani, J.; Srikanth, S.; Varghese, T.; Paez, M.; Desai, P.; Tirupathi, R.; Fabara, S.P.; et al. Crimean-Congo Hemorrhagic Fever Beyond Ribavirin: A Systematic Review. Cureus 2021, 13, doi:10.7759/cureus.17842.
9.  Brinkmann, A.; Uddin, S.; Krause, E.; Surtees, R.; Dinçer, E.; Kar, S.; Hacıoğlu, S.; Özkul, A.; Ergünay, K.; Nitsche, A. Utility of a Sequence-Independent, Single-Primer-Amplification (SISPA) and Nanopore Sequencing Approach for Detection and Characterization of Tick-Borne Viral Pathogens. Viruses 2021, 13, 203, doi:10.3390/v13020203.
10.  Madison-Antenucci, S.; Kramer, L.D.; Gebhardt, L.L.; Kauffman, E. Emerging Tick-Borne Diseases. Clinical Microbiology Reviews 2020, 33, 10.1128/cmr.00083-18, doi:10.1128/cmr.00083-18.
11.  Wahid, B.; Altaf, S.; Naeem, N.; Ilyas, N.; Idrees, M. Scoping Review of Crimean-Congo Hemorrhagic Fever (CCHF) Literature and Implications of Future Research. J Coll Physicians Surg Pak 2019, 29, 563–573, doi:10.29271/jcpsp.2019.06.563.
12.  Espy, N.; Pérez-Sautu, U.; Ramírez de Arellano, E.; Negredo, A.; Wiley, M.R.; Bavari, S.; Díaz Menendez, M.; Sánchez-Seco, M.P.; Palacios, G. Ribavirin Had Demonstrable Effects on the Crimean-Congo Hemorrhagic Fever Virus (CCHFV) Population and Load in a Patient With CCHF Infection. The Journal of Infectious Diseases 2018, 217, 1952–1956, doi:10.1093/infdis/jiy163.
13.  Sweileh, W.M. Global Research Trends of World Health Organization’s Top Eight Emerging Pathogens. Globalization and Health 2017, 13, 9, doi:10.1186/s12992-017-0233-9.
14.  Pigott, D.M.; Deshpande, A.; Letourneau, I.; Morozoff, C.; Reiner, R.C.; Kraemer, M.U.G.; Brent, S.E.; Bogoch, I.I.; Khan, K.; Biehl, M.H.; et al. Local, National, and Regional Viral Haemorrhagic Fever Pandemic Potential in Africa: A Multistage Analysis. The Lancet 2017, 390, 2662–2672, doi:10.1016/S0140-6736(17)32092-5.
15.  Lukashev, A.N.; Klimentov, A.S.; Smirnova, S.E.; Dzagurova, T.K.; Drexler, J.F.; Gmyl, A.P. Phylogeography of Crimean Congo Hemorrhagic Fever Virus. PLOS ONE 2016, 11, e0166744, doi:10.1371/journal.pone.0166744.
16.  Brackney, D.E.; Armstrong, P.M. Transmission and Evolution of Tick-Borne Viruses. Current Opinion in Virology 2016, 21, 67–74, doi:10.1016/j.coviro.2016.08.005.
17.  Bente, D.A.; Forrester, N.L.; Watts, D.M.; McAuley, A.J.; Whitehouse, C.A.; Bray, M. Crimean-Congo Hemorrhagic Fever: History, Epidemiology, Pathogenesis, Clinical Syndrome and Genetic Diversity. Antiviral Research 2013, 100, 159–189, doi:10.1016/j.antiviral.2013.07.006.
18.  Ascioglu, S.; Leblebicioglu, H.; Vahaboglu, H.; Chan, K.A. Ribavirin for Patients with Crimean–Congo Haemorrhagic Fever: A Systematic Review and Meta-Analysis. Journal of Antimicrobial Chemotherapy 2011, 66, 1215–1222, doi:10.1093/jac/dkr136.
19.  Soares-Weiser, K.; Thomas, S.; G, G.T.; Garner, P. Ribavirin for Crimean-Congo Hemorrhagic Fever: Systematic Review and Meta-Analysis. BMC Infectious Diseases 2010, 10, 207, doi:10.1186/1471-2334-10-207.
20.  Carroll, S.A.; Bird, B.H.; Rollin, P.E.; Nichol, S.T. Ancient Common Ancestry of Crimean-Congo Hemorrhagic Fever Virus. Molecular Phylogenetics and Evolution 2010, 55, 1103–1110, doi:10.1016/j.ympev.2010.01.006.
21.  Frank, M.G.; Weaver, G.; Raabe, V. Crimean Congo Hemorrhagic Fever Virus for Clinicians—Virology, Pathogenesis, and Pathology - Volume 30, Number 5—May 2024 - Emerging Infectious Diseases Journal - CDC., doi:10.3201/eid3005.231646.



## Nipah

- [Download Nipah Database](https://github.com/hivdb/GenBankRefs/releases/download/20250110/Nipah.db)


### Related literatures


1.  Tan, F.H.; Sukri, A.; Idris, N.; Ong, K.C.; Schee, J.P.; Tan, C.T.; Tan, S.H.; Wong, K.T.; Wong, L.P.; Tee, K.K.; et al. A Systematic Review on Nipah Virus: Global Molecular Epidemiology and Medical Countermeasures Development. Virus Evolution 2024, 10, veae048, doi:10.1093/ve/veae048.
2.  Meier, K.; Olejnik, J.; Hume, A.J.; Mühlberger, E. A Comparative Assessment of the Pathogenic Potential of Newly Discovered Henipaviruses. Pathogens 2024, 13, 587, doi:10.3390/pathogens13070587.
3.  de Campos, G.M.; Cella, E.; Kashima, S.; Alcântara, L.C.J.; Sampaio, S.C.; Elias, M.C.; Giovanetti, M.; Slavov, S.N. Updated Insights into the Phylogenetics, Phylodynamics, and Genetic Diversity of Nipah Virus (NiV). Viruses 2024, 16, 171, doi:10.3390/v16020171.
4.  Paul, D.; Mohanty, A.; Shah, A.; Kumar Padhi, B.; Sah, R. Outbreak of an Emerging Zoonotic Nipah Virus: An Emerging Concern. Journal of Biosafety and Biosecurity 2023, 5, 57–59, doi:10.1016/j.jobb.2023.04.002.
5.  Li, H.; Kim, J.-Y.V.; Pickering, B.S. Henipavirus Zoonosis: Outbreaks, Animal Hosts and Potential New Emergence. Front. Microbiol. 2023, 14, doi:10.3389/fmicb.2023.1167085.
6.  Jonkmans, N.; D’Acremont, V.; Flahault, A. Scoping Future Outbreaks: A Scoping Review on the Outbreak Prediction of the WHO Blueprint List of Priority Diseases. BMJ Global Health 2021, 6, e006623, doi:10.1136/bmjgh-2021-006623.
7.  Irving, A.T.; Ahn, M.; Goh, G.; Anderson, D.E.; Wang, L.-F. Lessons from the Host Defences of Bats, a Unique Viral Reservoir. Nature 2021, 589, 363–370, doi:10.1038/s41586-020-03128-0.
8.  Hauser, N.; Gushiken, A.C.; Narayanan, S.; Kottilil, S.; Chua, J.V. Evolution of Nipah Virus Infection: Past, Present, and Future Considerations. Tropical Medicine and Infectious Disease 2021, 6, 24, doi:10.3390/tropicalmed6010024.
9.  Lo, M.K.; Feldmann, F.; Gary, J.M.; Jordan, R.; Bannister, R.; Cronin, J.; Patel, N.R.; Klena, J.D.; Nichol, S.T.; Cihlar, T.; et al. Remdesivir (GS-5734) Protects African Green Monkeys from Nipah Virus Challenge. Science Translational Medicine 2019, 11, eaau9242, doi:10.1126/scitranslmed.aau9242.
10.  Lo Presti, A.; Cella, E.; Giovanetti, M.; Lai, A.; Angeletti, S.; Zehender, G.; Ciccozzi, M. Origin and Evolution of Nipah Virus. Journal of Medical Virology 2016, 88, 380–388, doi:10.1002/jmv.24345.
11.  Luby, S.P. The Pandemic Potential of Nipah Virus. Antiviral Research 2013, 100, 38–43, doi:10.1016/j.antiviral.2013.07.011.


## LASV

- [Download LASV Database](https://github.com/hivdb/GenBankRefs/releases/download/20250110/Lassa.db)



### Related literatures

1.  Reyna, R.A.; Littlefield, K.E.; Shehu, N.; Makishima, T.; Maruyama, J.; Paessler, S. The Importance of Lassa Fever and Its Disease Management in West Africa. Viruses 2024, 16, 266, doi:10.3390/v16020266.
2.  Moore, K.A.; Ostrowsky, J.T.; Mehr, A.J.; Johnson, R.A.; Ulrich, A.K.; Moua, N.M.; Fay, P.C.; Hart, P.J.; Golding, J.P.; Benassi, V.; et al. Lassa Fever Research Priorities: Towards Effective Medical Countermeasures by the End of the Decade. Lancet Infect Dis 2024, 24, e696–e706, doi:10.1016/S1473-3099(24)00229-9.
3.  He, C.-Q.; Kong, C.; He, M.; Chen, G.-X.; Liu, S.-M.; Ding, N.-Z. Intrasegmental Recombination as an Evolutionary Force of Lassa Fever Virus. Front. Microbiol. 2024, 15, doi:10.3389/fmicb.2024.1411537.
4.  Hastie, K.M.; Melnik, L.I.; Cross, R.W.; Klitting, R.M.; Andersen, K.G.; Saphire, E.O.; Garry, R.F. The Arenaviridae Family: Knowledge Gaps, Animal Models, Countermeasures, and Prototype Pathogens. The Journal of Infectious Diseases 2023, 228, S359–S375, doi:10.1093/infdis/jiac266.
5.  Garry, R.F. Lassa Virus Structural Biology and Replication. Curr Top Microbiol Immunol 2023, 440, 147–164, doi:10.1007/82_2023_262.
6.  Lassa Fever: Epidemiology, Immunology, Diagnostics, and Therapeutics; Garry, R., Ed.; Current Topics in Microbiology and Immunology; Springer International Publishing: Cham, 2023; Vol. 440; ISBN 978-3-031-35806-7.
7.  Viral Fitness and Evolution: Population Dynamics and Adaptive Mechanisms; Domingo, E., Schuster, P., Elena, S.F., Perales, C., Eds.; Current Topics in Microbiology and Immunology; Springer International Publishing: Cham, 2023; Vol. 439; ISBN 978-3-031-15639-7.
8.  Klitting, R.; Kafetzopoulou, L.E.; Thiery, W.; Dudas, G.; Gryseels, S.; Kotamarthi, A.; Vrancken, B.; Gangavarapu, K.; Momoh, M.; Sandi, J.D.; et al. Predicting the Evolution of the Lassa Virus Endemic Area and Population at Risk over the next Decades. Nat Commun 2022, 13, 5596, doi:10.1038/s41467-022-33112-3.
9.  Klitting, R.; Mehta, S.B.; Oguzie, J.U.; Oluniyi, P.E.; Pauthner, M.G.; Siddle, K.J.; Andersen, K.G.; Happi, C.T.; Sabeti, P.C. Lassa Virus Genetics. In Lassa Fever: Epidemiology, Immunology, Diagnostics, and Therapeutics; Garry, R., Ed.; Current Topics in Microbiology and Immunology; Springer International Publishing: Cham, 2020; Vol. 440, pp. 23–65 ISBN 978-3-031-35806-7.
10.  Kenmoe, S.; Tchatchouang, S.; Ebogo-Belobo, J.T.; Ka’e, A.C.; Mahamat, G.; Guiamdjo Simo, R.E.; Bowo-Ngandji, A.; Demeni Emoh, C.P.; Che, E.; Tchami Ngongang, D.; et al. Systematic Review and Meta-Analysis of the Epidemiology of Lassa Virus in Humans, Rodents and Other Mammals in Sub-Saharan Africa. PLoS Negl Trop Dis 2020, 14, e0008589, doi:10.1371/journal.pntd.0008589.
11.  Balogun, O.O.; Akande, O.W.; Hamer, D.H. Lassa Fever: An Evolving Emergency in West Africa. Am J Trop Med Hyg 2020, 104, 466–473, doi:10.4269/ajtmh.20-0487.
12.  Pontremoli, C.; Forni, D.; Sironi, M. Arenavirus Genomics: Novel Insights into Viral Diversity, Origin, and Evolution. Curr Opin Virol 2019, 34, 18–28, doi:10.1016/j.coviro.2018.11.001.
13.  Maes, P.; Alkhovsky, S.V.; Bào, Y.; Beer, M.; Birkhead, M.; Briese, T.; Buchmeier, M.J.; Calisher, C.H.; Charrel, R.N.; Choi, I.R.; et al. Taxonomy of the Family Arenaviridae and the Order Bunyavirales: Update 2018. Arch Virol 2018, 163, 2295–2310, doi:10.1007/s00705-018-3843-5.
14.  Mylne, A.Q.N.; Pigott, D.M.; Longbottom, J.; Shearer, F.; Duda, K.A.; Messina, J.P.; Weiss, D.J.; Moyes, C.L.; Golding, N.; Hay, S.I. Mapping the Zoonotic Niche of Lassa Fever in Africa. Transactions of The Royal Society of Tropical Medicine and Hygiene 2015, 109, 483–492, doi:10.1093/trstmh/trv047.
15.  Andersen, K.G.; Shapiro, B.J.; Matranga, C.B.; Sealfon, R.; Lin, A.E.; Moses, L.M.; Folarin, O.A.; Goba, A.; Odia, I.; Ehiane, P.E.; et al. Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus. Cell 2015, 162, 738–750, doi:10.1016/j.cell.2015.07.020.
16.  Djavani, M.; Lukashevich, I.S.; Sanchez, A.; Nichol, S.T.; Salvato, M.S. Completion of the Lassa Fever Virus Sequence and Identification of a RING Finger Open Reading Frame at the L RNA 5′ End. Virology 1997, 235, 414–418, doi:10.1006/viro.1997.8722.
17.  Auperin, D.D.; McCormick, J.B. Nucleotide Sequence of the Lassa Virus (Josiah Strain) S Genome RNA and Amino Acid Sequence Comparison of the N and GPC Proteins to Other Arenaviruses. Virology 1989, 168, 421–425, doi:10.1016/0042-6822(89)90287-0.



